Joseph R. Young - 13 Mar 2026 Form 4 Insider Report for Vera Therapeutics, Inc. (VERA)

Role
SVP, FINANCE, CHIEF ACCT OFFCR
Signature
/s/ Joseph R. Young
Issuer symbol
VERA
Transactions as of
13 Mar 2026
Net transactions value
$0
Form type
4
Filing time
16 Mar 2026, 18:52:14 UTC
Previous filing
25 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Young Joseph R SVP, FINANCE, CHIEF ACCT OFFCR C/O VERA THERAPEUTICS, INC., 2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE /s/ Joseph R. Young 16 Mar 2026 0001861684

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VERA Class A Common Stock Options Exercise +10,000 +15% $3.94* 75,754 13 Mar 2026 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VERA Stock Option (right to buy) Options Exercise -10,000 -21% $0.000000* 38,589 13 Mar 2026 Class A Common Stock 10,000 $3.94 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 1,032 shares acquired pursuant to the Company's 2021 Employee Stock Purchase Plan.
F2 1/4 of the shares subject to the option vested on March 9, 2022, and 1/48 of the shares vest monthly thereafter.